Matches in SemOpenAlex for { <https://semopenalex.org/work/W2534128519> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2534128519 abstract "e14552 Background: Transduction of chronic lymphocytic leukemia (CLL) cells with a replication-defective adenovirus (Ad) encoding recombinant CD154 (Ad-ISF35) induces expression of death receptors and Bid via a P53-independent pathway involving induction of P73. Induction of P73 significantly enhances the sensitivity of P53-defective CLL cells to “P53-dependent” drugs, such as Fludarabine (F-ara-A). Patients with P53-defective CLL who received iv infusions of autologous Ad-ISF35-transduced CLL cells were observed to achieve complete remissions (CR) with subsequent treatment using F-ara-A based treatment regimens, suggesting Ad-ISF35 could sensitize P53-defective CLL to chemotherapy. Methods: We examined patients with drug-resistant and/or P53-defective CLL before and after iv infusions of autologous Ad-ISF35-transduced CLL cells who were enrolled in a phase I study examining whether such treatment could sensitize patients to a truncated fludarabine, cyclophosphamide and rituximab (FCR) regimen. We examined CLL cells for sensitivity to F-ara-A in vitro, expression of CD95, DR5, Bid, and P73 and correlated these with the response to treatment in vivo. Results: P53-defective CLL cells were resistant to F-ara-A induced apoptosis with IC50 > 10μM prior to treatment. CLL cells collected from patients≥24 hours after IV infusion of autologous Ad-ISF35-trasduced CLL cells became sensitive to the cytotoxic effects of F-ara-A, with IC50 0.3–1 μM. Enhanced sensitivity to F-ara-A was associated with induced expression of Bid, DR5, CD95, and P73 by circulating CLL cells, an effect lasting≥2 weeks following iv infusion. Consistent with this, we observed complete resolution in lymphocytosis, lymphadenopathy and splenomegaly following 1 cycle of FCR administered 2 weeks after 3 biweekly infusions of Ad-ISF35- transduced CLL cells. Conclusions: IV infusion of autologous Ad-ISF35-transduced CLL cells can induce de novo, systemic expression of death receptors and Bid on bystander CLL cells, which is associated with enhanced sensitivity of P53-defective CLL to the cytotoxic effects of standard chemotherapy [Table: see text]" @default.
- W2534128519 created "2016-10-28" @default.
- W2534128519 creator A5016707073 @default.
- W2534128519 creator A5036974252 @default.
- W2534128519 creator A5042680843 @default.
- W2534128519 creator A5047295587 @default.
- W2534128519 creator A5047903125 @default.
- W2534128519 creator A5054108202 @default.
- W2534128519 creator A5063442680 @default.
- W2534128519 creator A5078848675 @default.
- W2534128519 date "2009-05-20" @default.
- W2534128519 modified "2023-09-26" @default.
- W2534128519 title "Ad-ISF35-transduced autologous cells promote in vitro and in vivo chemosensitization in patients with 17p-/P53-defective chronic lymphocytic leukemia" @default.
- W2534128519 doi "https://doi.org/10.1200/jco.2009.27.15_suppl.e14552" @default.
- W2534128519 hasPublicationYear "2009" @default.
- W2534128519 type Work @default.
- W2534128519 sameAs 2534128519 @default.
- W2534128519 citedByCount "0" @default.
- W2534128519 crossrefType "journal-article" @default.
- W2534128519 hasAuthorship W2534128519A5016707073 @default.
- W2534128519 hasAuthorship W2534128519A5036974252 @default.
- W2534128519 hasAuthorship W2534128519A5042680843 @default.
- W2534128519 hasAuthorship W2534128519A5047295587 @default.
- W2534128519 hasAuthorship W2534128519A5047903125 @default.
- W2534128519 hasAuthorship W2534128519A5054108202 @default.
- W2534128519 hasAuthorship W2534128519A5063442680 @default.
- W2534128519 hasAuthorship W2534128519A5078848675 @default.
- W2534128519 hasConcept C126322002 @default.
- W2534128519 hasConcept C150903083 @default.
- W2534128519 hasConcept C154317977 @default.
- W2534128519 hasConcept C202751555 @default.
- W2534128519 hasConcept C203014093 @default.
- W2534128519 hasConcept C207001950 @default.
- W2534128519 hasConcept C2776694085 @default.
- W2534128519 hasConcept C2776755627 @default.
- W2534128519 hasConcept C2777938653 @default.
- W2534128519 hasConcept C2778461978 @default.
- W2534128519 hasConcept C2779234475 @default.
- W2534128519 hasConcept C2779263901 @default.
- W2534128519 hasConcept C2780790343 @default.
- W2534128519 hasConcept C39347974 @default.
- W2534128519 hasConcept C502942594 @default.
- W2534128519 hasConcept C55493867 @default.
- W2534128519 hasConcept C71924100 @default.
- W2534128519 hasConcept C86803240 @default.
- W2534128519 hasConceptScore W2534128519C126322002 @default.
- W2534128519 hasConceptScore W2534128519C150903083 @default.
- W2534128519 hasConceptScore W2534128519C154317977 @default.
- W2534128519 hasConceptScore W2534128519C202751555 @default.
- W2534128519 hasConceptScore W2534128519C203014093 @default.
- W2534128519 hasConceptScore W2534128519C207001950 @default.
- W2534128519 hasConceptScore W2534128519C2776694085 @default.
- W2534128519 hasConceptScore W2534128519C2776755627 @default.
- W2534128519 hasConceptScore W2534128519C2777938653 @default.
- W2534128519 hasConceptScore W2534128519C2778461978 @default.
- W2534128519 hasConceptScore W2534128519C2779234475 @default.
- W2534128519 hasConceptScore W2534128519C2779263901 @default.
- W2534128519 hasConceptScore W2534128519C2780790343 @default.
- W2534128519 hasConceptScore W2534128519C39347974 @default.
- W2534128519 hasConceptScore W2534128519C502942594 @default.
- W2534128519 hasConceptScore W2534128519C55493867 @default.
- W2534128519 hasConceptScore W2534128519C71924100 @default.
- W2534128519 hasConceptScore W2534128519C86803240 @default.
- W2534128519 hasLocation W25341285191 @default.
- W2534128519 hasOpenAccess W2534128519 @default.
- W2534128519 hasPrimaryLocation W25341285191 @default.
- W2534128519 hasRelatedWork W1976032451 @default.
- W2534128519 hasRelatedWork W2189490116 @default.
- W2534128519 hasRelatedWork W2557262035 @default.
- W2534128519 hasRelatedWork W2586379992 @default.
- W2534128519 hasRelatedWork W2586991593 @default.
- W2534128519 hasRelatedWork W2601705700 @default.
- W2534128519 hasRelatedWork W2765482011 @default.
- W2534128519 hasRelatedWork W3114113751 @default.
- W2534128519 hasRelatedWork W3144806708 @default.
- W2534128519 hasRelatedWork W2105571216 @default.
- W2534128519 isParatext "false" @default.
- W2534128519 isRetracted "false" @default.
- W2534128519 magId "2534128519" @default.
- W2534128519 workType "article" @default.